Figure 5.
Frequency of LMP2-specific T cells in responding vs nonresponding patients. PB samples at set time points after T-cell infusion were incubated with LMP2 pepmixes and then plated in interferon-γ enzyme-linked immunospot assays. Responding patients (A) had a slightly greater frequency of LMP2-specific T cells than nonresponders (B).